# The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg

> **NCT02893124** · PHASE4 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** peginterferon alfa

## Key facts

- **NCT ID:** NCT02893124
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02893124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02893124, "The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02893124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*